These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25709431)

  • 1. A novel chemosynthetic peptide with β-sheet motif efficiently kills Klebsiella pneumoniae in a mouse model.
    Tan S; Gan C; Li R; Ye Y; Zhang S; Wu X; Yang YY; Fan W; Wu M
    Int J Nanomedicine; 2015; 10():1045-59. PubMed ID: 25709431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graphene oxide as an efficient antimicrobial nanomaterial for eradicating multi-drug resistant bacteria in vitro and in vivo.
    Wu X; Tan S; Xing Y; Pu Q; Wu M; Zhao JX
    Colloids Surf B Biointerfaces; 2017 Sep; 157():1-9. PubMed ID: 28554055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short Synthetic β-Sheet Antimicrobial Peptides for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Burn Wound Infections.
    Zhong G; Cheng J; Liang ZC; Xu L; Lou W; Bao C; Ong ZY; Dong H; Yang YY; Fan W
    Adv Healthc Mater; 2017 Apr; 6(7):. PubMed ID: 28135045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lyn regulates inflammatory responses in Klebsiella pneumoniae infection via the p38/NF-κB pathway.
    Li X; Zhou X; Ye Y; Li Y; Li J; Privratsky B; Wu E; Gao H; Huang C; Wu M
    Eur J Immunol; 2014 Mar; 44(3):763-73. PubMed ID: 24338528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.
    Wu G; Wu P; Xue X; Yan X; Liu S; Zhang C; Shen Z; Xi T
    Peptides; 2013 Jul; 45():73-7. PubMed ID: 23643614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
    Lepak AJ; Andes DR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae.
    Oliva A; Gizzi F; Mascellino MT; Cipolla A; D'Abramo A; D'Agostino C; Trinchieri V; Russo G; Tierno F; Iannetta M; Mastroianni CM; Vullo V
    Clin Microbiol Infect; 2016 Feb; 22(2):147-153. PubMed ID: 26409059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality.
    Capone A; Giannella M; Fortini D; Giordano A; Meledandri M; Ballardini M; Venditti M; Bordi E; Capozzi D; Balice MP; Tarasi A; Parisi G; Lappa A; Carattoli A; Petrosillo N
    Clin Microbiol Infect; 2013 Jan; 19(1):E23-E30. PubMed ID: 23137235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved.
    Ostorhazi E; Holub MC; Rozgonyi F; Harmos F; Cassone M; Wade JD; Otvos L
    Int J Antimicrob Agents; 2011 May; 37(5):480-4. PubMed ID: 21353493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Gallium Citrate Formulations against a Multidrug-Resistant Strain of Klebsiella pneumoniae in a Murine Wound Model of Infection.
    Thompson MG; Truong-Le V; Alamneh YA; Black CC; Anderl J; Honnold CL; Pavlicek RL; Abu-Taleb R; Wise MC; Hall ER; Wagar EJ; Patzer E; Zurawski DV
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6484-93. PubMed ID: 26239978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Hirsch EB; Guo B; Chang KT; Cao H; Ledesma KR; Singh M; Tam VH
    J Infect Dis; 2013 Mar; 207(5):786-93. PubMed ID: 23242537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Anti-Infective Pulmonary Proteins: In Vivo Cooperative Action of Surfactant Protein SP-A and the Lung Antimicrobial Peptide SP-BN.
    Coya JM; Akinbi HT; Sáenz A; Yang L; Weaver TE; Casals C
    J Immunol; 2015 Aug; 195(4):1628-36. PubMed ID: 26163587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
    Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A
    Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.
    Tumbarello M; Trecarichi EM; De Rosa FG; Giannella M; Giacobbe DR; Bassetti M; Losito AR; Bartoletti M; Del Bono V; Corcione S; Maiuro G; Tedeschi S; Celani L; Cardellino CS; Spanu T; Marchese A; Ambretti S; Cauda R; Viscoli C; Viale P;
    J Antimicrob Chemother; 2015 Jul; 70(7):2133-43. PubMed ID: 25900159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.
    Pan CY; Chen JC; Chen TL; Wu JL; Hui CF; Chen JY
    Mar Drugs; 2015 Apr; 13(4):2287-305. PubMed ID: 25874924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients.
    Orsi GB; García-Fernández A; Giordano A; Venditti C; Bencardino A; Gianfreda R; Falcone M; Carattoli A; Venditti M
    J Hosp Infect; 2011 May; 78(1):54-8. PubMed ID: 21450365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience.
    Veeraraghavan B; Shankar C; Karunasree S; Kumari S; Ravi R; Ralph R
    Pathog Glob Health; 2017 Jul; 111(5):240-246. PubMed ID: 28670975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
    Ni W; Li G; Zhao J; Cui J; Wang R; Gao Z; Liu Y
    Infect Dis (Lond); 2018 Jul; 50(7):507-513. PubMed ID: 29316830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience.
    Lübbert C; Faucheux S; Becker-Rux D; Laudi S; Dürrbeck A; Busch T; Gastmeier P; Eckmanns T; Rodloff AC; Kaisers UX
    Int J Antimicrob Agents; 2013 Dec; 42(6):565-70. PubMed ID: 24100228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.